eicker.news ᳇ tech news1d ago
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
Variety2d ago

Eli Lilly Links to ESPN’s Pat Summitt Reunion Special, Seeking New Ways to Tell Medical Stories
#Variety #News #EliLilly #ESPN #PatSummitt

https://variety.com/2026/tv/news/eli-lilly-espn-pat-summitt-reunion-special-pharmaceutical-1236702145/

Eli Lilly Links to ESPN Pat Summitt Reunion, Seeking Medical Stories

Eli Lilly Links to ESPN's Pat Summitt Special, Seeking New Ways to Tell Medical Stories

Variety
Yonhap Infomax NewsMar 17
Celltrion secures CMO contract worth up to 375.4 billion won with undisclosed global pharma company, pushing Q1 cumulative orders past 1 trillion won following earlier Eli Lilly deal, as CDMO partnership inquiries surge
#YonhapInfomax #Celltrion #CMO #BiopharmaceuticalAPI #EliLilly #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=110249
Celltrion Signs Drug Supply Deal Worth Up to 375.4 Billion Won with Global Pharma

Celltrion secures CMO contract worth up to 375.4 billion won with undisclosed global pharma company, pushing Q1 cumulative orders past 1 trillion won following earlier Eli Lilly deal, as CDMO partnership inquiries surge

Yonhap Infomax
PPC LandMar 13
FYI: Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up: Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers. https://ppc.land/amazon-pharmacy-adds-zepbound-kwikpen-at-299-as-glp-1-race-heats-up/ #AmazonPharmacy #ZepboundKwikPen #GLP1 #Healthcare #EliLilly
Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up

Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers.

PPC Land
PPC LandMar 11
ICYMI: Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up: Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers. https://ppc.land/amazon-pharmacy-adds-zepbound-kwikpen-at-299-as-glp-1-race-heats-up/ #AmazonPharmacy #Zepbound #KwikPen #GLP1 #EliLilly
Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up

Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers.

PPC Land
Ken Everett (Ken's Blogspot)Mar 6

#ARAI Testing #NewSUV in #Pune Chery Jaecoo
https://kensbookinfo.blogspot.com/p/business.html#5

#AI Agents Love to Hold #Bitcoin and Spend Stablecoins,
https://kensbookinfo.blogspot.com/p/etc-varied.html#6

#EliLilly launches program to help boost employer coverage
https://kensbookinfo.blogspot.com/p/business.html#40

In defense of student walkout protests against #ICE
https://kensbookinfo.blogspot.com/p/politics.html#14

#Vermonters face federal clean water changes
https://kensbookinfo.blogspot.com/p/us-capitals.html#Montpelier

#Iranian artists react to current events
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris

#US Deputy Secy Landau
https://kensbookinfo.blogspot.com/p/cities.html#41a

Business

NewsletterTFMar 6

Novo Nordisk Faces Shifting Weight-Loss Drug Market

Novo Nordisk forecasts sales drop of 5-13% in 2026 for Wegovy and Ozempic due to rivals like Eli Lilly. Learn how this affects drug prices and future growth.

#NovoNordisk, #Wegovy, #Ozempic, #WeightLossDrugs, #EliLilly

https://newsletter.tf/novo-nordisk-wegovy-sales-drop-2026-competition/

NewsletterTFMar 6

Novo Nordisk's sales are expected to drop by 5% to 13% in 2026, ending years of strong growth. This is due to new weight-loss drugs from competitors.

#NovoNordisk, #Wegovy, #Ozempic, #WeightLossDrugs, #EliLilly

https://newsletter.tf/novo-nordisk-wegovy-sales-drop-2026-competition/

Novo Nordisk's Wegovy Sales Drop 5-13% in 2026 Due to New Competition

Novo Nordisk forecasts sales drop of 5-13% in 2026 for Wegovy and Ozempic due to rivals like Eli Lilly. Learn how this affects drug prices and future growth.

Yonhap Infomax NewsFeb 26
Celltrion Co. has implemented measures to ensure its US business remains unaffected by any tariff policy changes, leveraging local production and inventory to maintain stable operations.
#YonhapInfomax #Celltrion #USTariffs #BranchburgPlant #EliLilly #BusinessOperations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106952
Celltrion Says US Tariff Issue Will Not Disrupt Business Operations in Any Scenario

Celltrion Co. has implemented measures to ensure its US business remains unaffected by any tariff policy changes, leveraging local production and inventory to maintain stable operations.

Yonhap Infomax
Yonhap Infomax NewsFeb 23
Novo Nordisk shares plunged 14% in pre-market trading after clinical trial data showed its new obesity drug CagriSema delivered less weight loss than Eli Lilly’s rival, prompting plans for further studies.
#YonhapInfomax #NovoNordisk #CagriSema #EliLilly #ObesityDrug #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106390
Shares in Novo Nordisk Plunge 14% as Next-Generation Obesity Drug Falls Short of Expectations

Novo Nordisk shares plunged 14% in pre-market trading after clinical trial data showed its new obesity drug CagriSema delivered less weight loss than Eli Lilly’s rival, prompting plans for further studies.

Yonhap Infomax